Moonshots EP 139: Bitcoin vs. Stocks — What’s the Smarter Investment? (AMA) w/ Salim Ismail

Summary

An AMA format episode where Diamandis and Salim Ismail field audience questions across crypto, BCI, healthcare AI, energy, and career advice. The Bitcoin thesis dominates: Diamandis declares he would “much rather put my money into Bitcoin than an aggregate fund today,” citing outperformance over every other asset class and predicting $300K by end of 2025. He endorses Michael Saylor’s MicroStrategy playbook of using corporate bonds to buy Bitcoin and hints at an upcoming podcast on implementing that strategy.

On index funds, Ismail contributes meaningful data: his EXO organization studied Fortune 100 companies and found the most flexible/adaptable organizations delivered 40x shareholder returns over 7 years vs. least adaptable. Diamandis recommends small biotech index funds, predicting the sector will rebound after four years of regulatory decimation.

The healthcare AI segment cites a study showing AI-only diagnosis at ~90% accuracy vs. physician-only at ~70% and physician+AI at ~75% — the counterintuitive finding that human physicians injecting bias actually degrades AI accuracy. Both hosts advocate for regulatory reform, with Ismail calling it “the most promising aspect of the incoming administration.”

Energy discussion covers perovskite solar (30% conversion rate vs. 20% for silicon PV, 40% cheaper, no rare earths — Diamandis advises Paranova), 4th-gen nuclear for hyperscaler datacenters, and fusion timeline skepticism (Ismail argues solar+storage will arrive first). On BCI, Diamandis teases the company Science (CEO Max Hodak) using “tens of millions” of interface points vs. Neuralink’s thousands, without disclosing the mechanism.

Bias/Sponsor Notes

Standard triple ad reads (Fountain Life, Viome, OneSkin — all Diamandis portfolio/affiliated companies). Bitcoin advocacy is extremely bullish with zero discussion of downside risk, volatility, or regulatory uncertainty. The $300K prediction is presented as though it’s conservative. Ismail’s EXO study is self-referential (promoting his own organization’s framework). Healthcare AI statistics are cited without source attribution. The Paranova perovskite mention is disclosed as an advisory relationship.